Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongxia Gao

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standardJennifer R Won, Dongxia Gao, Christine Chow, et al.
BMC Cancer|September 6, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinomaBasile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, et al.
JAMA Oncology|July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialShuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Calculator for ovarian carcinoma subtype predictionSteve E Kalloger, Martin Köbel, Samuel Leung, et al.
Oncoimmunology|April 22, 2020
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomasAmanda R Dancsok, Dongxia Gao, Anna F Lee, et al.
Oncoimmunology|May 24, 2021
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabineElisabeth S Stovgaard, Karama Asleh, Nazia Riaz, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Cell Reports|June 11, 2020
Phospho-Ser<sup>784</sup>-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast CancerCuige Zhu, Anna Rogers, Karama Asleh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Preclinical Efficacy and Safety Assessment of an Antibody-Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast CarcinomaMinh Nguyen, Shuichi Miyakawa, Junichi Kato, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standardJennifer R Won, Dongxia Gao, Christine Chow, et al.
BMC Cancer|September 6, 2017
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinomaBasile Tessier-Cloutier, Steve E Kalloger, Mohammad Al-Kandari, et al.
JAMA Oncology|July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialShuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Calculator for ovarian carcinoma subtype predictionSteve E Kalloger, Martin Köbel, Samuel Leung, et al.
Oncoimmunology|April 22, 2020
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomasAmanda R Dancsok, Dongxia Gao, Anna F Lee, et al.
Oncoimmunology|May 24, 2021
The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabineElisabeth S Stovgaard, Karama Asleh, Nazia Riaz, et al.
Journal of the National Cancer Institute|October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
Cell Reports|June 11, 2020
Phospho-Ser<sup>784</sup>-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast CancerCuige Zhu, Anna Rogers, Karama Asleh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Preclinical Efficacy and Safety Assessment of an Antibody-Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast CarcinomaMinh Nguyen, Shuichi Miyakawa, Junichi Kato, et al.
Histopathology|July 13, 2016
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptorKarama Asleh-Aburaya, Brandon S Sheffield, Zuzana Kos, et al.
Pageof 6